Literature DB >> 9178811

Chromosome 16 in primary prostate cancer: a microsatellite analysis.

I Osman1, H Scher, G Dalbagni, V Reuter, Z F Zhang, C Cordon-Cardo.   

Abstract

Cytogenetic and molecular genetic analyses of prostate cancer specimens have revealed nonrandom chromosomal deletions, affecting chromosomes 7q, 8p, 10q and 16q. Based on these data, we designed this study to further characterize the altered region(s) on chromosome 16 by evaluating 16 microsatellite markers on a population composed of 32 paired normal and primary prostatic tumor samples. The 16 microsatellites selected mapped to 11 distinct loci on 16q and 5 loci on 16p. No alterations were identified affecting 16p. However, 16 of 31 (51%) informative cases showed molecular alterations in at least one of the loci analyzed on 16q, consisting of 18 deletions and 11 bandshifts. Moreover, most of the deletions clustered at 6 microsatellite loci, mapping to the 16q22.1-23.1 region. Our results suggest that microsatellite alterations on the long arm of chromosome 16 are frequent events in prostate cancer, and that the 16q22.1-23.1 region might harbor a tumor suppressor gene involved in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178811     DOI: 10.1002/(sici)1097-0215(19970516)71:4<580::aid-ijc12>3.0.co;2-g

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 2.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

3.  Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms.

Authors:  Tamara Cacev; Mladen Jokić; Radan Spaventi; Kresimir Pavelić; Sanja Kapitanović
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-08       Impact factor: 4.553

4.  Copy number alterations are associated with metastatic-lethal progression in prostate cancer.

Authors:  Xiaoyu Wang; Catherine S Grasso; Kristina M Jordahl; Suzanne Kolb; Yaw A Nyame; Jonathan L Wright; Elaine A Ostrander; Dean A Troyer; Raymond Lance; Ziding Feng; James Y Dai; Janet L Stanford
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-02-18       Impact factor: 5.554

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.